FectoPRO is a transfection reagent specifically optimized for transient protein and antibody expression in CHO and HEK293 cells.
Meet our team at booth #74 during the Cell Therapy Manufacturing and Gene Therapy Congress in Amsterdam (The Netherlands), December 3 – 6th, 2019.
Talk by Margherita Neri, Upstream Process Development Manager from Molmed
Critical raw materials in Large scale LV productions for ex vivo gene therapy
Wednesday, 4 December 2019, 15:30.
Addressing Large-Scale Therapeutic Virus Production Using High Quality Grade PEI-based Transfection Reagents
Our solutions for Cell Manufacturing
in vivo delivery of nucleic acids represents a novel promising approach for some medical applications such as gene and oligonucleotides therapy. Polyplus-transfection® offers a cGMP grade in vivo-jetPEI® which is manufactured in compliance with applicable European Commission (EC) guide to Good Manufacturing Practices (GMP) and FDA requirements for clinical trials phase I to III. This reagent is used worldwide for a growing number of therapies based on nucleic acid delivery.
NEW: in vivo-jetRNA+® transfection reagent specifically developed to deliver mRNA in vivo. This reagent can be used to target multiple organs, by using systemic or local injection routes, in various animal models.
FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).
The convention will take place at RAI Amsterdam (Europaplein, 1078 GZ Amsterdam, The Netherlands):